Phase I and pharmacokinetic trial of aminopterin in patients with refractory malignancies

Journal of Clinical Oncology

Volumn 16, Issue 4, 1998, Pages 1458-1464

  Ratliff, Arleen F ^a   Wilson, Jennifer ^a   Hum, Martina ^a   Marling Cason, Margaret ^a   Rose, Kathy ^a   Winick, Naomi ^a   Kamen, Barton A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPTERIN; FOLINIC ACID; METHOTREXATE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BONE MARROW TOXICITY; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LUNG TOXICITY; MALE; MALIGNANT NEOPLASTIC DISEASE; MAXIMUM PERMISSIBLE DOSE; MUCOSA INFLAMMATION; NERVE SHEATH TUMOR; NEUROTOXICITY; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN TOXICITY;

EID: 0031954699     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.4.1458     Document Type: Article

References (31)

1. Farber S, Diamond LK, Mercer RD, et al: Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-aminopteroylglutamic acid (aminopterin). N Engl J Med 238:787-793, 1948
2. Goldin A, Venditti JM, Humphreys SR, et al: A quantitative comparison of the antileukemic effectiveness of two folic acid antagonists in mice. J Natl Cancer Inst 15:1657-1664, 1955
3. Bertino JR, Kamen B, Romanini A: Folic Acid Antagonists, in Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR (eds): Cancer Medicine (ed 4). Philadelphia, PA, Williams & Wilkins, 1996, pp 907-922
4. Pappo A, Dubowy R, Ravindranath Y, et al: Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Natl Cancer Inst 82:1641-1642, 1990
5. Rodriguez G, Brown TD, Balis FM, et al: A phase I trial of TMTX on a daily times five schedule in patients with refractory adult leukemia. Anticancer Drugs 4:163-166, 1993
6. Balis FM, Patel R, Luks E, et al: Pediatric phase I trial and pharmacokinetic study of trimetrexate. Cancer Res 47:4973-4976, 1987
7. Takimoto CH, Allegra: New antifolates in clinical development. Oncology 9:649-659, 1995
8. Peters GJ, Ackland SP: New antimetabolites in preclinical and clinical development. Exp Opin Invest Drugs 5:637-679, 1996
9. Wiesenfeld M, Jett JR, Su JQ, et al: Phase II trial of edatrexate in small-cell lung cancer. Cancer 73:1189-1193, 1994
10. Knowling M, Bramwell V, Eisenhauer E, et al: Phase II trial of 10-EDAM in advanced soft tissue sarcoma. Ann Oncol 5:766-768, 1994
11. Moore DF, Pazdur R, Abbruzzese JL, et al: Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma. Ann Oncol 5:286-287, 1994
12. Pazdur R, Moore DF, Bready B, et al: Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma. Ann Oncol 5:646-648, 1994
13. Vandenberg TA, Pritchard KI, Eisenhauer EA, et al: Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: A National Cancer Institute of Canada Clinical Trials Group study. J Clin Oncol 11:1241-1244, 1993
14. Kuebler JP, Benedetti J, Schuller DE, et al: Phase II study of edatrexate in advanced head and neck cancer: A Southwest Oncology Group study. Invest New Drugs 12:341-344, 1994
15. Garrow TA, Shane B: Purification and general properties of human folylpolyglutamate synthetase, in Ayling JE, Nair MG, Baugh CM (eds): Chemistry and Biology of Pteridines and Folates. New York, NY, Plenum, 1993, pp 659-662
16. Smith A, Hum M, Winick N, et al: A case for the use of aminopterin in treatment of patients with leukemia based upon metabolic studies of blasts in vitro. Clin Cancer Res 2:1-5, 1996
17. Winick N, Shuster JJ, Bowman WP, et al: Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia. J Clin Oncol 14:2803-2811, 1996
18. Glode LM, Pitman SW, Ensminger WD, et al: A phase I trial of high doses of aminopterin with leucovorin rescue in patients with advanced metastatic tumors. Cancer Res 39:3707-3714, 1979
19. Kamen BA, Takach PL, Vatek R, et al: A rapid, radiochemical-ligand binding assay for methotrexate. Anal Biochem 70:54-63, 1976
20. Ronge E, Kjellman B: Long-term treatment with betaine in methylenetetrahydrofolate reductase deficiency. Arch Dis Child 74:239-241, 1996
21. Wilken DEL, Wilken B, Dudman PB, et al: Homocystinuria -the effects of betaine in the treatment of patients not responsive to pyridoxine. N Engl J Med 309:448-453, 1983
22. Yamamoto J-I, Horie T, Awazu S: Amelioration of methotrexate-induced malabsorption by vitamin A. Cancer Chemother Pharmacol 39:239-244, 1997
23. Farrow AC, Buchanan GR, Zwiener RJ, et al: Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 15:1560-1566, 1997
24. Englebrecht JA, Calhoon SL, Scherrer JJ: Methotrexate pneumonitis after low dose therapy for rheumatoid arthritis. Arthritis Rheum 26:1275-1278, 1983
25. Sostman HD, Matthay RA, Putman CE, et al: Methotrexate induced pneumonitis. Medicine 55:371-381, 1976
26. Searles G, McKendry R: Methotrexate pneumonitis in rheumatoid arthritis: Potential risk factors. Four case reports and a review of the literature. J Rheum 14:1164-1171, 1987
27. Whitehead VM, Rosenblatt DS, Vuchich MJ, et al: Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: A pilot prognostic factor analysis. Blood 76:44-49, 1990
28. Vogler WR, Jacobs J: Toxic and therapeutic effects of methotrexate-folinic acid (leucovorin) in advanced cancer and leukemia. Cancer 28:894-901, 1971
29. Hryniuk WM, Bertino JR: Treatment of leukemia with large doses of methotrexate and folinic acid: Clinical-biochemical correlates. J Clin Invest 48:2140-2155, 1969
30. Pizzo PA, Henderson ES, Leventhal BG: Acute myelogenous leukemia in children: A preliminary report of combination chemotherapy. J Pediatr 88:125-130, 1976
31. Skeel RT, Marsh JC, DeConti RC, et al: Development of a combination chemotherapy program for adult leukemia: CAM and ACM-L. Cancer 32:76-81, 1973